Dr. Bubis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Florida Cancer Specialists (MBG)
1658 St. Vincent's Way
Middleburg, FL 32068Phone+1 904-269-6526Fax+1 904-269-6527- Is this information wrong?
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2005
- Philadelphia College of Osteopathic MedicineChief Residency, Internal Medicine, 2001 - 2002
- Philadelphia College of Osteopathic MedicineResidency, Internal Medicine, 2000 - 2002
- Philadelphia College of Osteopathic MedicineInternship, Transitional Year, 1999 - 2000
- Philadelphia College of Osteopathic MedicineClass of 1999
- Temple UniversityB.S., Biology, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
- FL State License 2005 - 2026
- PA State License 2000 - 2002
- AOA Board of Internal Medicine Hematology
- AOA Board of Internal Medicine Oncology
- Licensed in Florida (active) and Pennsylvania (inactive) Board Certified in Internal Medicine, Medical Oncology, and Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
- Top Docs Jacksonville Magazine, 2012
- Patients’ Choice Award Vitals.com, 2009
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsTITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancerDenise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky, David Drosick, Fred J. Kudrik, Linda D. Bosserman, Mark Keaton, Sharon A. Goble,...> ;Breast Cancer Research and Treatment. 2017 May 15
- 216 citationsRandomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung CancerJoachim von Pawel, Robert M. Jotte, David R. Spigel, Mary O'Brien, Mark A. Socinski, J. Mezger, Martin Steins, Léon Bosquee, Jeffrey A. Bubis, Kristiaan Nackaerts, Jos...> ;Journal of Clinical Oncology. 2014 Nov 10
- 7 citationsTrimodality Therapy for Stage II-III Carcinoma of the Esophagus: A Dose-Ranging Study of Concurrent Capecitabine, Docetaxel, and Thoracic RadiotherapyMatthew D. Wood, Bassem I. Zaki, Stuart R. Gordon, John E. Sutton, Mikhail Lisovsky, Jiang Gui, Jeffrey A. Bubis, Konstantin H. Dragnev, James R. Rigas> ;Journal of Thoracic Oncology. 2013 Apr 1
- Join now to see all
Journal Articles
- Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancerPawel J, Jotte R, Spigel DR, O’Brien MER, Socinski MA, Mezger J, Steins M, Bosuee L, Bubis J, Nackaerts K, Trigo JM, Clinigan P, Schutte, Lorigan P, Reck M, Domine M, ..., JCO, 1/1/2014
- Trimodality therapy for stage II-III carcinoma of the esophagus: A dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapyWood MD, Zaki BI, Gordon SR, Sutton JE, Lisovsky M, Gui J, Bubis JA, Dragnev KH, Rigas JR, Journal of Thoracic Oncology, 1/1/2013
- First-line use of cabazitaxel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm study in comparison with docetaxelOudard S, Sengelov L, Mainwaring PN, Thiery-Vuillemin A, Theodore,C, Kulukov E, Yachnin J, Kocak I, Kataja VV, Luukkaa M, Nosov A, Hjelm-Eriksson M, Bubis J, et al, J Clin Oncol, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Features of patients (pts) with metastatic breast cancer (mBC) and a circulating tumor cell count (CTCc) of 0Bubis JA, Marsland TA, Justice KM, Edwards D, San Antonio Breast Cancer Symposium, 1/1/2007
- Aneusomy of chromosome (chrom) 17: an alternative mechanism of low level HER-2/neu gene amplification that correlates with immunohistochemical (IHC) 2+ protein expressionKaufman PA, Schwartz GN, Bubis JA, Cates J, Wells WA, Moore CP, Connelly EM, Muss HB, Weaver DL, San Antonio Breast Cancer Symposium, 1/1/2004
- Docetaxel and carboplatin followed by a dose-ranging study of oral capecitabine, weekly docetaxel, and concomitant external beam radiotherapy for the treatment of pati...Bubis JA, Rigas JR, Dragnev KH, Sutton JE, Gordon SR, Zaki B, Cole BF, Williams I, American Society of Clinical Oncology Annual Meeting, 1/1/2004
- Join now to see all
Lectures
- Genomic Oncology1/1/2017
- Cancer Treatment in the Elderly1/1/2016
- New Options in Metastatic Colorectal Cancer1/1/2015
- Join now to see all
Press Mentions
- Can Engaging in Oral Sex Increase Your Risk of Head and Neck Cancer?July 28th, 2023
Professional Memberships
- Member
- Member
Hospital Affiliations
- Baptist Medical Center JacksonvilleJacksonville, Florida
- HCA Florida Orange Park HospitalOrange Park, Florida
- HCA Florida Putnam HospitalPalatka, Florida
- Ascension St. Vincent's Clay CountyMiddleburg, Florida
- Baptist Medical Center SouthJacksonville, Florida
External Links
- Florida Cancer Specialistshttps://flcancer.com/en/physician/jeffrey-bubis-do-facoi-facp/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: